Grantable
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant · THE PFIZER FOUNDATION INC
$50,000–$200,000
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: US $50,000 - US $200,000 Last Updated: June 11, 2025 Summary The Pfizer competitive grant program for Real-World Data Generati…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.